Work

A salvage chemotherapy of R-P-IMVP16/CBDCA consisting of rituximab, methylprednisolone, ifosfamide, methotrexate, etoposide, and carboplatin for patients with diffuse large B cell lymphoma who had previously received R-CHOP therapy as first-line chemother

Year: 2016

Type: article

Source: Hematological Oncology

DOI: 10.1002/hon.2285

Authors: Takuro Matsumoto, Takeshi Hara, Yuhei Shibata, Nobuhiko Nakamura, Hiroshi Nakamura, Soranobu Ninomiya, Junichi Kitagawa, Nobuhiro Kanemura, Naoe Goto, Yusuke Kito, Senji Kasahara, Toshiki Yamada, Michio Sawada, Tatsuhiko Miyazaki, Tsuyoshi Takami, Tamotsu Takeuchi, Hisataka Moriwaki, Hisashi Tsurumi

Institutions: Gifu University, Gifu Municipal Hospital, Gifu Prefectural General Medical Center, Gifu Red Cross Hospital, Gifu University Hospital

Language: English

Topic: Lymphoma Diagnosis and Treatment

Subfield: Pathology and Forensic Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funder: Japan Society for the Promotion of Science

Award: Blocking the arylhydrocarbon receptor for cancer immunotherapy

OpenAlex ID: W2303716633

FWCI: 1.672

Cites: 31

Cited by: 8

Related to: 10